REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

89

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

September 17, 2025

Study Completion Date

December 30, 2025

Conditions
Heart Failure
Interventions
DRUG

REGN5381

Single dose intravenous (IV) infusion

DRUG

Placebo

Single dose IV infusion

Trial Locations (44)

1500

Worthwhile Clinical Trials, Benoni

1618

Arensia Exploratory Medicine Clinic at MBAL Sveta Sofia, Sofia

3000

UZ Leuven, Leuven

3570

Anima Research Center, Alken

4000

Centre Hospitalier Regional de la Citadelle, Liège

University Multiprofile Hospital for Active Treatment Plovdiv, Plovdiv

4321

Dr M I Sarvan,R Moodley & partners, Durban

6060

Grand Hopital de Charleroi, Gilly

6300

MHAT Haskovo, Haskovo

7580

Kuils River Hospital, Kuils River

8000

Algemeen Ziekenhuis St Jan Brugge Oostende Av, Bruges

8308

Korea University Guro Hospital, Seoul

8400

AZ Oostende, Ostend

8500

Algemeen Ziekenhuis Groeninge, Kortrijk

9300

Onze Lieve Vrouw Ziekenhuis Aalst, Aalst

11521

Athens Naval Hospital, Athens

11527

First Cardiology Clinic University of Athens, Athens

11650

Virgen de las Montañas Hospital, Villamartín

11658

Arensia Exploratory Medicine Clinic at Monza Bucharest, Bucharest

12462

General University Hospital Attikon, Chaïdári

13620

Seoul National University Bundang Hospital, Seongnam-si

15006

Fakultni Nemocnice v Motole, Prague

25001

Medicus Services s.r.o., Brandýs nad Labem-Stará Boleslav

26426

Wonju Severance Christian Hospital, Wŏnju

30120

Hospital Universitario Virgen de la Arrixaca, El Palmar

32789

Flourish Research - Orlando (Formerly Clinical Site Partners), Winter Park

33186

Flourish Research - Miami (Kendall) (Formerly Clinical Site Partners), Miami

41009

Hospital Universitario Virgen Macarena Unidad Coronaria 1 planta, Seville

41110

Larissa University Hospital, Larissa

46015

Hospital Arnau de Vilanova, Valencia

55101

Edumed, Jaroměř

62500

University Hospital Brno, Brno

85015

Arensia Exploratory Medicine Clinic, Phoenix

90509

Harbor UCLA Medical Center, Torrance

400006

Sc Arensia Exploratory Medicine Srl, Cluj-Napoca

0112

Arensia Exploratory Medicine at the Research Institute of Clinical Medicine, Tbilisi

MD-2025

Pmsi Republican Clinical Hospital Timofei Mosneaga, Chisinau

87-100

Wojewodzki Szpital Zespolony - Ludwik Rydygier Provincial Hospital, Torun

02-097

UCK Medical University of Warsaw, Warsaw

90-549

Medical University of Lodz, Lodz

62-571

NZOZ Gemini, Żychlin

96-100

Clinmedica Research sp zo.o., Skierniewice

0181

Into Research, Groenkloof

03722

Severance Hospital at Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT06237309 - REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction | Biotech Hunter | Biotech Hunter